How Ozanimod Could Hold Big Potential For Crohn’s Disease
Covidien announced on Monday that Merck (MRK) said that a final analysis of its clinical trial involving an investigational single-tablet immunotherapy called Ozanimod for Crohn’s disease showed that the drug had a modest impact…